Personal information

Countries

Netherlands

Activities

Collapse all

Employment (1)

St. Antonius Ziekenhuis: Nieuwegein, Utrecht, NL

2021-02-01 to present | PhD candidate (Cardiology)
Employment
Source: Self-asserted source
Wout van den Broek

Education and qualifications (1)

Universiteit Maastricht Faculty of Health Medicine and Life Sciences: Maastricht, Limburg, NL

2018-01-02 to 2020-12-31 | Master's Degree
Education
Source: Self-asserted source
Wout van den Broek

Works (15)

Cost-effectiveness of implementing a genotype-guided de-escalation strategy in patients with acute coronary syndrome

European Heart Journal - Cardiovascular Pharmacotherapy
2024-11-13 | Journal article
DOI: 10.1093/ehjcvp/pvae087
Contributors: Wout Willem Antoon van den Broek; Jaouad Azzahhafi; Dean R P P Chan Pin Yin; Niels M R van der Sangen; Shabiga Sivanesan; Lea M Dijksman; Ronald J Walhout; Melvyn Tjon Joe Gin; Nicoline J Breet; Jorina Langerveld et al.
Source: check_circle
Crossref

Genotype-Guided Antiplatelet Therapy

Journal of the American College of Cardiology
2024-09 | Journal article
DOI: 10.1016/j.jacc.2024.06.038
Contributors: Wout W.A. van den Broek; Brenden S. Ingraham; Naveen L. Pereira; Craig R. Lee; Larisa H. Cavallari; Jesse J. Swen; Dominick J. Angiolillo; Jurriën M. ten Berg
Source: check_circle
Crossref

Real-World Implementation of a Genotype-Guided P2Y12 Inhibitor De-Escalation Strategy in Acute Coronary Syndrome Patients

JACC: Cardiovascular Interventions
2024-09 | Journal article
DOI: 10.1016/j.jcin.2024.06.020
Contributors: Jaouad Azzahhafi; Wout W.A. van den Broek; Dean R.P.P. Chan Pin Yin; Niels M.R. van der Sangen; Shabiga Sivanesan; Salahodin Bofarid; Joyce Peper; Daniel M.F. Claassens; Paul W.A. Janssen; Ankie M. Harmsze et al.
Source: check_circle
Crossref

The puzzle of antiplatelet therapy in ACS: ticagrelor monotherapy is another missing piece

European Heart Journal
2024-09-01 | Journal article
DOI: 10.1093/eurheartj/ehae440
Contributors: Wout W A van den Broek; Jurriën M ten Berg
Source: check_circle
Crossref

P2Y12 Inhibition in Patients Requiring Oral Anticoagulation after Percutaneous Coronary Intervention: The SWAP-AC–2 Study

JACC: Cardiovascular Interventions
2024-04 | Journal article
DOI: 10.1016/j.jcin.2024.03.027
Contributors: Luis Ortega-Paz; Wilbert Bor; Francesco Franchi; Wout W.A. van de Broek; Fabiana Rollini; Salvatore Giordano; Mattia Galli; Latonya Been; Ghussan Ghanem; Awss Shalhoub et al.
Source: check_circle
Crossref

Conservative versus Invasive Strategy in Elderly Patients with Non-ST-Elevation Myocardial Infarction: Insights from the International POPular Age Registry

Journal of Clinical Medicine
2023-08-22 | Journal article
DOI: 10.3390/jcm12175450
Contributors: Wout W. A. van den Broek; Marieke E. Gimbel; Dean R. P. P. Chan Pin Yin; Jaouad Azzahhafi; Renicus S. Hermanides; Craig Runnett; Robert F. Storey; David Austin; Rohit Oemrawsingh; Justin Cooke et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Another Step Toward CYP2C19 Genotype-Guided Therapy in Treatment With Dual Antiplatelet Therapy

JACC: Cardiovascular Interventions
2023-04 | Journal article
DOI: 10.1016/j.jcin.2023.02.008
Part of ISSN: 1936-8798
Contributors: Jurriën M. ten Berg; Wout W.A. van den Broek
Source: Self-asserted source
Wout van den Broek

CYP2C9 Polymorphisms and the Risk of Cardiovascular Events in Patients Treated with Clopidogrel: Combined Data from the POPular Genetics and POPular AGE Trials

American Journal of Cardiovascular Drugs
2023-03 | Journal article
DOI: 10.1007/s40256-022-00565-2
Contributors: Wout W. A. van den Broek; Nabil Mani; Jaouad Azzahhafi; Jurriën M. ten Berg
Source: check_circle
Crossref

Dual antiplatelet therapy de-escalation in acute coronary syndrome: an individual patient meta-analysis

European Heart Journal
2023-03-08 | Journal article
DOI: 10.1093/eurheartj/ehac829
Part of ISSN: 0195-668X
Part of ISSN: 1522-9645
Contributors: Jeehoon Kang; Konstantinos D Rizas; Kyung Woo Park; Jaewook Chung; Wout van den Broek; Daniel M F Claassens; Eun ho Choo; Dániel Aradi; Steffen Massberg; Doyeon Hwang et al.
Source: Self-asserted source
Wout van den Broek

Cost-effectiveness of clopidogrel vs. ticagrelor in patients of 70 years or older with non-ST-elevation acute coronary syndrome

European Heart Journal - Cardiovascular Pharmacotherapy
2022-12-15 | Journal article
DOI: 10.1093/ehjcvp/pvac037
Contributors: Wout W A van den Broek; Jacqueline G van Paassen; Marieke E Gimbel; Vera H M Deneer; Jurriën M ten Berg; Rick A Vreman
Source: check_circle
Crossref

Effects of CYP3A4*22 and CYP3A5 on clinical outcome in patients treated with ticagrelor for ST-segment elevation myocardial infarction: POPular Genetics sub-study

Frontiers in Pharmacology
2022-12-05 | Journal article
DOI: 10.3389/fphar.2022.1032995
Part of ISSN: 1663-9812
Contributors: Jaouad Azzahhafi; Thomas O. Bergmeijer; Wout W. A. van den Broek; Dean R. P. P. Chan Pin Yin; Senna Rayhi; Joyce Peper; Willem L. Bor; Daniel M. F. Claassens; Ron H. N. van Schaik; Jurriën M. ten Berg
Source: Self-asserted source
Wout van den Broek

Is a genotype-guided therapy the optimal strategy to personalize anti-thrombotic management in patients with acute coronary syndrome?

European Heart Journal
2022-11-14 | Journal article
DOI: 10.1093/eurheartj/ehac219
Contributors: Wout W A van den Broek; Jurriën M ten Berg
Source: check_circle
Crossref

Global Longitudinal Strain is Incremental to Left Ventricular Ejection Fraction for the Prediction of Outcome in Optimally Treated Dilated Cardiomyopathy Patients

Journal of the American Heart Association
2022-03-15 | Journal article
DOI: 10.1161/JAHA.121.024505
Contributors: Anne G. Raafs; Andrea Boscutti; Michiel T. H. M. Henkens; Wout W. A. van den Broek; Job A. J. Verdonschot; Jerremy Weerts; Davide Stolfo; Vincenzo Nuzzi; Paolo Manca; Mark R. Hazebroek et al.
Source: check_circle
Crossref

Genotype-guided antithrombotic therapy

Ned Tijdschr Geneeskd
2022-01-24 | Journal article
Source: Self-asserted source
Wout van den Broek

Is there Benefit for Cyp2C19 Genotype-Guided Antiplatelet Treatment in Elderly Acute Coronary Syndrome Patients?

Pharmacogenomics
2021-08 | Journal article
DOI: 10.2217/pgs-2021-0078
Contributors: Wout WA van den Broek; Jurriën M ten Berg
Source: check_circle
Crossref

Peer review (5 reviews for 3 publications/grants)

Review activity for Drugs - real world outcomes. (1)
Review activity for European heart journal. (2)
Review activity for Heart. (2)
How many people are using ORCID?